Similarly, miR-331-3p down-regulates E2F1 to promote the development and metastasis of HCC, indicating the possible application of miR-331-3p in predicting the prognosis and treatment of HCC [28]. This evidence concerns the gene E2F1 and hepatocellular carcinoma.